Literature DB >> 10364773

Diagnosis and management of inherited and acquired thrombophilias.

F A Spencer1, R C Becker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10364773     DOI： 10.1023/a:1008817116524

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  114 in total

Review 1.  Acquired circulating anticoagulants.

Authors:  L A Kunkel
Journal:  Hematol Oncol Clin North Am       Date:  1992-12       Impact factor: 3.722

2.  Impaired catalytic function of activated protein C: a new in vitro manifestation of lupus anticoagulant.

Authors:  E Marciniak; E H Romond
Journal:  Blood       Date:  1989-11-15       Impact factor: 22.113

3.  Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V.

Authors:  J Voorberg; J Roelse; R Koopman; H Büller; F Berends; J W ten Cate; K Mertens; J A van Mourik
Journal:  Lancet       Date:  1994-06-18       Impact factor: 79.321

4.  Antithrombin III mutation database: first update. For the Thrombin and its Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.

Authors:  D A Lane; R J Olds; M Boisclair; V Chowdhury; S L Thein; D N Cooper; M Blajchman; D Perry; J Emmerich; M Aiach
Journal:  Thromb Haemost       Date:  1993-08-02       Impact factor: 5.249

5.  Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.

Authors:  M den Heijer; T Koster; H J Blom; G M Bos; E Briet; P H Reitsma; J P Vandenbroucke; F R Rosendaal
Journal:  N Engl J Med       Date:  1996-03-21       Impact factor: 91.245

6.  Thromboembolic disease--critical evaluation of laboratory investigation.

Authors:  J Malm; M Laurell; I M Nilsson; B Dahlbäck
Journal:  Thromb Haemost       Date:  1992-07-06       Impact factor: 5.249

7.  Congenital thrombophilia among patients with venous thromboembolism.

Authors:  E Melissari; G Monte; V S Lindo; K D Pemberton; N V Wilson; R Edmondson; S Das; V V Kakkar
Journal:  Blood Coagul Fibrinolysis       Date:  1992-12       Impact factor: 1.276

8.  Normal fetal growth in women with antiphospholipid syndrome treated with high-dose intravenous immunoglobulin (IVIG).

Authors:  H Valensise; E Vaquero; C De Carolis; E Stipa; R Perricone; D Arduini; C Romanini
Journal:  Prenat Diagn       Date:  1995-06       Impact factor: 3.050

9.  Bleeding and thromboembolism during anticoagulant therapy: a population-based study in Rochester, Minnesota.

Authors:  M J Gitter; T M Jaeger; T M Petterson; B J Gersh; M D Silverstein
Journal:  Mayo Clin Proc       Date:  1995-08       Impact factor: 7.616

10.  Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study.

Authors:  T Koster; F R Rosendaal; H de Ronde; E Briët; J P Vandenbroucke; R M Bertina
Journal:  Lancet       Date:  1993 Dec 18-25       Impact factor: 79.321
View more
  1 in total

1.  Association of oral estradiol dose/levels with coagulation measures in early/late postmenopausal women.

Authors:  I Sriprasert; H N Hodis; B Bernick; S Mirkin; W J Mack
Journal:  Climacteric       Date:  2020-01-15       Impact factor: 3.005
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.